HOME >> BIOLOGY >> NEWS
Why results from genetic tests should be available to medical insurance companies

Authors of a Viewpoint article in this week's issue of THE LANCET discuss the ethical considerations surrounding genetic test results and disclosure to medical insurance companies-the authors outline their reasons for supporting the disclosure of such test results to make health insurance more equitable.

Nick Raithatha and Richard D. Smith from the University of East anglia, UK, discuss the public concern that genetic testing will be misused by insurers, discriminating between those identified as low risk and high risk. The ethical arguments related to this concern rely on the nature and predictive power of the test, the requirement for the test, and disclosure of the test result. The authors discuss these issues, using the example of two individuals at increased risk of coronary heart disease. Individual A has a higher risk of the disease compared with the age and sex adjusted average, identified by a blood cholesterol test, and individual B has the same increase in risk, but it was identified by a hypothetical genetic test. At present, individual A has to declare this information to the insurance company, whereas individual B does not.

The authors comment: 'Our contention is that this situation is unjustifiable, that genetic testing poses no new ethical issues compared with already accepted (non-genetic) practices adopted by insurance companies, but rather that the present inconsistency concerning disclosure of results of genetic and non-genetic based tests seems unethical. The shortage of information on the links between genetic status, lifestyle, and future health might make use of genetic tests inappropriate, rather than unethical, for premium assessment. However, with the rapid progress made in the area of genetics, these links may soon be clearly established, and our contention is based on this development.'

Dr. Raithatha concludes: "Perhaps the biggest obstacle remains public perception of genetic testing. The primary task facing the me
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
29-Jan-2004


Page: 1 2

Related biology news :

1. Warren Pharmaceuticals publishes results of preclinical evaluation
2. U of T microbiologists achieve results with pattern recognition software
3. Loss of circadian genes results in epilepsy
4. VIB presents its annual results at BIO2004 in San Francisco
5. Scientists discover why not enough choline results in fewer brain cells, poorer memory
6. Heart and lung transplantation clinical trial results to be announced at ISHLT meeting
7. Sequencing project results in six-fold reduction of effective size of maize genome
8. VaxGen reports Phase I clinical trial results of anthrax vaccine candidate
9. Duke open-air experiment results could deflate hopes that forests can alleviate global warming
10. Studies suggest brain injury results from developmental exposure to alcohol, anesthesia, and lead
11. Applying results of womens health initiative study to individual patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2020)... Mass. (PRWEB) , ... June 24, 2020 , ... ... of cloud-based enterprise software and software-driven clinical data services that accelerate drug development, ... for low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This ...
(Date:6/23/2020)... ... 22, 2020 , ... The field of quantitation of large molecules or proteins ... this area. However, the use of mass spectrometry in this field has gained a ... “How do you choose which approach to use (LBA or MS)?” In many ...
(Date:6/19/2020)... ... ... The director of stem cell biotechnology company Asymmetrex , Dr. James L. ... have easier access to stem cell counting, they will soon make it a routine ... weekend in the U.S., Asymmetrex is offering free tissue stem cell counting at its ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... WOODLANDS, Texas (PRWEB) , ... August 06, 2020 ... ... therapy and DNA vaccine industries, announces it has closed on the purchase of ... Technology Park in Conroe, TX and includes over 21 acres in the initial ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International ... only $3950. With 50 million stem cells total, patients may choose which extremities they ... works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue ...
(Date:7/31/2020)... SHREWSBURY, Mass. (PRWEB) , ... July 29, 2020 ... ... clad wire that can combine up to three different materials for use with ... can combine up to three materials to meet specific design requirements, performance, and ...
(Date:7/31/2020)... ... July 29, 2020 , ... The ... radiation centers in 16 countries, has reached its 20th anniversary of worldwide use. ... routine use at top universities including University of Pennsylvania, University of Michigan, University ...
Breaking Biology Technology:
Cached News: